Inaugural AACR International Meeting - Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application
In-Person Event
Jun 22 - 26, 2018
Boston, Massachusetts, USA
OVERVIEW
Inaugural AACR International Meeting - Advances in Malignant Lymphoma: Maximizing the Basic-Translational Interface for Clinical Application is organized by American Association for Cancer Research (AACR) and will be held during Jun 22 - 26, 2018 at Boston Marriott Copley Place, Boston, Massachusetts, United States of America. This CME Conference has been approved for a maximum of 27.75 AMA PRA Category 1 Credits.
Conference Description :
The program was designed to take advances in basic research areas and discuss how those are being applied, or have the potential to be applied for the betterment of patients in the clinic. Physician-scientists and clinicians will leave this program with new knowledge in the fields of gene editing, liquid biopsies, precision medicine trial design, early disease detection, and immunotherapy.
Conference Objectives are :
• Articulate the potential advantages, challenges, and limitations of CAR-T cell therapy for Non-Hodgkin Lymphoma.
• Provide an overview of the opportunities and challenges facing the implementation of liquid biopsies as an alternative to tissue biopsies for clinical decision making.
• Explain how clonal dynamics and tumor heterogeneity affect clinical outcome.
• Evaluate the potential for lymphoma MATCH trials and provide rationale or support for this approach.
Additional details will be posted as soon as they are available.
Conference Description :
The program was designed to take advances in basic research areas and discuss how those are being applied, or have the potential to be applied for the betterment of patients in the clinic. Physician-scientists and clinicians will leave this program with new knowledge in the fields of gene editing, liquid biopsies, precision medicine trial design, early disease detection, and immunotherapy.
Conference Objectives are :
• Articulate the potential advantages, challenges, and limitations of CAR-T cell therapy for Non-Hodgkin Lymphoma.
• Provide an overview of the opportunities and challenges facing the implementation of liquid biopsies as an alternative to tissue biopsies for clinical decision making.
• Explain how clonal dynamics and tumor heterogeneity affect clinical outcome.
• Evaluate the potential for lymphoma MATCH trials and provide rationale or support for this approach.
Additional details will be posted as soon as they are available.
KEY DATES
22 Jun, 2018
Event Start Date
26 Jun, 2018
Event End Date
SPECIALITIES
Hematology Blood and Marrow TransplantOncologySUGGESTED HOTELS
CONFERENCE VENUE
Boston Marriott Copley PlaceRELATED CONFERENCES & LIVE WEBINARS
Quick Links